微管脱聚合在狗体内使心肌收缩功能正常化,这些狗体有压力过重的左心室缩
M Koide1, M Hamawaki, T Narishige
1Gazes Cardiac Research Institute, Medical University of South Carolina, Charleston, SC 29403, USA.
Circulation
|August 30, 2000
概括
心脏细胞中微管子密度增加有助于压力过载期间收缩功能障碍. 在实验性大动脉狭窄症的狗中,用素去聚合微管恢复了心脏功能.
科学领域:
- 心血管生理学心血管生理学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 心肌缩可能会发展为心力衰竭.
- 微管网络密度的增加是这种过渡的一个拟议机制.
- 这种细胞骨异常通过施加粘性负荷来抑制心细胞收缩.
研究的目的:
- 在体内调查心细胞微管网密度增加的作用.
- 测试这种细胞骨异常是否有助于在实验性大动脉狭窄症中收缩功能障碍.
- 为了确定微管脱聚合能否恢复心脏功能.
主要方法:
- 在成年狗中诱导实验性大动脉狭窄,以产生压力过载.
- 测量左心室 (LV) 功能之前和之后,科尔奇辛的管理.
- 通过活检检查心脏细胞在治疗前和治疗后.
主要成果:
- 研究了严重的LV压力过载和收缩功能障碍的狗.
- 静脉内输入的科尔奇辛导致了微管的脱聚合.
- 微管脱聚合恢复了LV收缩功能,无论是体内还是体外.
结论:
- 心脏细胞微管网密度增加是心室收缩功能障碍的一个关键机制.
- 这种功能障碍发生在大型哺乳动物中,成人开始的压力过载引起的心脏缩.
- 准微管网可能为心力衰竭提供治疗潜力.
相关概念视频
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...


